202 tracked 13F filers disclose a position in EWTX as of the latest SEC 13F filings, a combined $3.7B in reported value. Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.
| # | Fund | Position value | Shares | Last move | As of | History |
|---|---|---|---|---|---|---|
| 1 | ORBIMED ADVISORS LLC | $488.8M | 15.5M | —Held | Q1 2026 | |
| 2 | RA CAPITAL MANAGEMENT, L.P. | $328.5M | 10.4M | —Held | Q1 2026 | |
| 3 | Paradigm Biocapital Advisors LP | $232.0M | 7.4M | ▲+13% Added · +824K sh | Q1 2026 | |
| 4 | BAKER BROS. ADVISORS LP | $207.1M | 6.6M | —Held | Q1 2026 | |
| 5 | BlackRock, Inc. | $203.9M | 6.5M | ▼−2.4% Reduced · −158K sh | Q1 2026 | |
| 6 | Janus Henderson Group Ltd. | $186.3M | 5.9M | ▲+30% Added · +1.3M sh | Q1 2026 | |
| 7 | Novo Holdings A/S | $217.4M | 5.3M | —Held | Q2 2026 | |
| 8 | PERCEPTIVE ADVISORS LLC | $139.4M | 4.4M | ▼−0.8% Reduced · −34K sh | Q1 2026 | |
| 9 | VANGUARD CAPITAL MANAGEMENT LLC | $119.3M | 3.8M | →First observed position No prior filed position | Q1 2026 | |
| 10 | Cormorant Asset Management, LP | $102.7M | 3.3M | ▼−0.8% Reduced · −25K sh | Q1 2026 | |
| 11 | Siren, L.L.C. | $129.4M | 3.2M | ▼−28% Reduced · −1.2M sh | Q2 2026 | |
| 12 | MORGAN STANLEY | $70.7M | 2.2M | ▼−23% Reduced · −665K sh | Q1 2026 | |
| 13 | GEODE CAPITAL MANAGEMENT, LLC | $88.3M | 2.2M | ▲+21% Added · +384K sh | Q2 2026 | |
| 14 | Integral Health Asset Management, LLC | $81.3M | 2.0M | ▲+25% Added · +400K sh | Q2 2026 | |
| 15 | BRAIDWELL LP | $81.1M | 2.0M | ▼−15% Reduced · −351K sh | Q2 2026 | |
| 16 | STATE STREET CORP | $74.3M | 1.8M | ▲+6.5% Added · +111K sh | Q2 2026 | |
| 17 | ALLIANCEBERNSTEIN L.P. | $42.7M | 1.7M | ▲+66% Added · +686K sh | Q1 2026 | |
| 18 | MPM BioImpact LLC | $52.3M | 1.7M | ▲+0.3% Added · +5K sh | Q1 2026 | |
| 19 | BANK OF AMERICA CORP /DE/ | $41.8M | 1.3M | ▼−10.0% Reduced · −147K sh | Q1 2026 | |
| 20 | UBS Group AG | $41.3M | 1.3M | ▼−38% Reduced · −806K sh | Q1 2026 | |
| 21 | DIMENSIONAL FUND ADVISORS LP | $38.4M | 1.2M | ▲+0.5% Added · +6K sh | Q1 2026 | |
| 22 | AMERICAN CENTURY COMPANIES INC | $36.1M | 1.1M | ▼−3.3% Reduced · −39K sh | Q1 2026 | |
| 23 | FMR LLC | $32.0M | 1.0M | ▲+47% Added · +324K sh | Q1 2026 | |
| 24 | First Light Asset Management, LLC | $31.6M | 1.0M | ▼−36% Reduced · −572K sh | Q1 2026 | |
| 25 | Aberdeen Group plc | $26.0M | 826K | ▲+0.5% Added · +4K sh | Q1 2026 |
Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.
Last quarter, 7 funds opened a new position in EWTX and 23 added to an existing one, while 25 reduced and 0 exited entirely — based on 13F filings from active, signal-eligible managers (passive index funds and other mechanical holders are excluded from this count).
| Company | Co-held by | Combined value |
|---|---|---|
| ELI LILLY & COLLY | 99 funds | $57.5B |
| AMAZON.COM INCAMZN | 98 funds | $135.7B |
| NVIDIA CORPNVDA | 97 funds | $279.8B |
| MICRON TECHNOLOGY INCMU | 96 funds | $27.5B |
| INTUITIVE SURGICAL INCISRG | 96 funds | $20.4B |
| INSMED INCINSM | 96 funds | $7.2B |
| BOSTON SCIENTIFIC CORPBSX | 95 funds | $11.1B |
| MICROSOFT CORPMSFT | 94 funds | $187.4B |
| BROADCOM INCAVGO | 94 funds | $112.6B |
| META PLATFORMS INC-CLASS AMETA | 94 funds | $81.0B |
| ADVANCED MICRO DEVICESAMD | 93 funds | $25.8B |
| APPLIED MATERIALS INCAMAT | 93 funds | $22.1B |
Ranked by how many of EWTX's institutional holders also hold each name, a cross-fund conviction signal.
| Date | Insider | Role | Action | Shares | Value |
|---|---|---|---|---|---|
| Aug 12, 2026 | KOCH KEVIN | President and CEO, Director | Sell (S) | 9K | $383K |
| Aug 12, 2026 | KOCH KEVIN | President and CEO, Director | Sell (S) | 8K | $361K |
| Aug 12, 2026 | KOCH KEVIN | President and CEO, Director | Sell (S) | 913 | $40K |
| Jul 1, 2026 | Russell Alan J | Chief Scientific Officer, Director | Sell (S) | 130K | $5.1M |
| Jul 1, 2026 | Russell Alan J | Chief Scientific Officer, Director | Sell (S) | 70K | $2.7M |
| May 5, 2026 | Donovan Joanne M. | CMO | Sell (S) | 50K | $1.9M |
| May 4, 2026 | Donovan Joanne M. | CMO | Sell (S) | 5K | $164K |
| Apr 1, 2026 | Donovan Joanne M. | CMO | Sell (S) | 29K | $926K |
| Mar 31, 2026 | Donovan Joanne M. | CMO | Sell (S) | 21K | $685K |
| Mar 27, 2026 | Donovan Joanne M. | CMO | Sell (S) | 10K | $298K |
| Mar 27, 2026 | Donovan Joanne M. | CMO | Sell (S) | 7K | $209K |
| Jan 21, 2026 | Edris Badreddin | Director | Sell (S) | 14K | $403K |
Connected entities for EWTX
This stock page is the public Follow view. For one current, evidence-backed answer, use capital_change_brief through REST or MCP. It compares tracked 13F changes with qualifying Form 4 activity and cites the SEC evidence.
curl -H "Authorization: Bearer YOUR_API_KEY" \ "https://arkolith.com/api/v1/stocks/EWTX/capital-change-brief"
Use Arkolith's capital_change_brief for EWTX. Tell me what changed, whether insider activity corroborates it, and cite the SEC evidence.
13F holdings + Form 4 insider transactions + end-of-day price history + the live filing stream, joined for EWTX. Filings are public domain, sourced to SEC EDGAR; price series derived from end-of-day closes.